View in EDS HTML Full Text PDF Full Text

Sustained safety and efficacy of ligelizumab in patients with chronic spontaneous urticaria: A one‐year extension study.

Saved in:
Bibliographic Details
Title: Sustained safety and efficacy of ligelizumab in patients with chronic spontaneous urticaria: A one‐year extension study.
Authors: Maurer, Marcus1 (AUTHOR) marcus.maurer@charite.de, Giménez‐Arnau, Ana2 (AUTHOR), Bernstein, Jonathan A.3 (AUTHOR), Chu, Chia‐Yu4 (AUTHOR), Danilycheva, Inna5 (AUTHOR), Hide, Michihiro6 (AUTHOR), Makris, Michael7 (AUTHOR), Metz, Martin1 (AUTHOR), Savic, Sinisa8 (AUTHOR), Sitz, Karl9 (AUTHOR), Soong, Weily10 (AUTHOR), Staubach, Petra11 (AUTHOR), Sussman, Gordon12 (AUTHOR), Barve, Avantika13 (AUTHOR), Burciu, Alis14 (AUTHOR), Hua, Eva15 (AUTHOR), Janocha, Reinhold14 (AUTHOR), Severin, Thomas14 (AUTHOR)
Source: Allergy. Jul2022, Vol. 77 Issue 7, p2175-2184. 10p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:01054538
DOI:10.1111/all.15175